Eli Radiopharma Secures Nearly RMB 400 Million in Series A Funding to Advance Radiopharmaceutical Pipeline
Trendline

Eli Radiopharma Secures Nearly RMB 400 Million in Series A Funding to Advance Radiopharmaceutical Pipeline

What's Happening? Hangzhou Eli Radiopharma Co., Ltd., an innovative radiopharmaceutical company focusing on integrated diagnostics and therapeutics for oncology and neurological diseases, has successfully completed a Series A financing round, raising nearly RMB 400 million. The funding round was led
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.